2021
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.
Lancet (London, England)
•Research at a glance
Top areas of exploration
- Diabetes Mellitus, Type 1 , 4 publications
- Diabetes Mellitus, Type 2 , 4 publications
- Anticoagulants , 3 publications
- Atrial Fibrillation , 3 publications
Research activity
My publications
Filter publications
70 publications
2021
Using machine learning to identify diabetes patients with canagliflozin prescriptions at high-risk of lower extremity amputation using real-world data.
Pharmacoepidemiology and drug safety
•2020
Comparison of Oral Anticoagulant Use and Stroke Risk Among Older Adults Newly-Diagnosed Atrial Fibrillation Living in Urban-Versus-Rural Areas.
The American journal of cardiology
2020
Costs and outcomes of "intermediate" vs "minimal" care for youth-onset type 1 diabetes in six countries.
Pediatric diabetes
•2020
Mediation analysis for estimating cardioprotection of longitudinal RAS inhibition beyond lowering blood pressure and albuminuria in type 1 diabetes.
Annals of epidemiology
•